Therapeutic efficacy of SJA6017, a calpain inhibitor, in rat spinal cord injury-Reference-Cited by-同舟云学术

Therapeutic efficacy of SJA6017, a calpain inhibitor, in rat spinal cord injury

Published:2008-10 Issue:10 Volume:15 Page:1130-1136
ISSN:0967-5868
Container-title:Journal of Clinical Neuroscience
language:en
Short-container-title:Journal of Clinical Neuroscience

Author:

Akdemir Osman,Uçankale Murat,Karaoğlan Alper,Barut Şeref,Sağmanligil Ayhan,Bilguvar Kaya,Çirakoğlu Beyazit,Şahan Elife,Çolak Ahmet

Publisher

Elsevier BV

Subject

Physiology (medical),Neurology (clinical),Neurology,General Medicine,Surgery

Reference43 articles.

1. Review of current evidence for apoptosis after spinal cord injury;Beattie;J Neurotrauma,2000

2. Evidence for apoptosis of oligodendroglia in long tracts undergoing Wallerian degeneration after spinal cord injury (SCI) in monkeys;Bresnahan;Soc Neurosci Abstr,1996

3. Oligodendroglial apoptosis occurs along degenerating axons and is associated with FAS and p75 expression following spinal cord injury in the rat;Casha;Neuroscience,2001

4. Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys;Crowe;Nat Med,1997

5. Apoptotic and anti-apoptotic mechanisms following spinal cord injury;Keane;J Neuropathol Exp Neurol,2001

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Investigation of liquid chromatography–mass spectrometry analysis of a peptide aldehyde SJA6017 with identifying its hemiacetal, gem‐diol, and enol ether;Journal of Mass Spectrometry;2024-04-24

2. Mechanism of skeletal muscle atrophy after spinal cord injury: A narrative review;Frontiers in Nutrition;2023-03-03

3. Cell-Permeable Calpain Inhibitor SJA6017 Provides Functional Protection to Spinal Motoneurons Exposed to MPP+;Neurotoxicity Research;2020-08-06

4. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease;Cell Research;2020-06-15

5. Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease;2020-04-20